Standout Papers

Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two p... 2018 2026 2020 2023 345
  1. Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo‐controlled trials (2018)
    James B. Bussel, Donald M. Arnold et al. American Journal of Hematology
  2. Randomized comparison of low dose cytarabine with or without glasdegib in patients with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndrome (2018)
    Jörge E. Cortes, Florian H. Heidel et al. Leukemia

Immediate Impact

1 by Nobel laureates 11 from Science/Nature 62 standout
Sub-graph 1 of 23

Citing Papers

Transferrin receptor targeting chimeras for membrane protein degradation
2024 StandoutNature
Polymeric Nanoparticles for Drug Delivery
2024 Standout
2 intermediate papers

Works of Andrzej Hellmann being referenced

Randomized comparison of low dose cytarabine with or without glasdegib in patients with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndrome
2018 Standout
Ofatumumab As Single-Agent CD20 Immunotherapy in Fludarabine-Refractory Chronic Lymphocytic Leukemia
2010

Author Peers

Author Last Decade Papers Cites
Andrzej Hellmann 1759 1442 1242 56 3.0k
Kathryn S. Kolibaba 1916 1000 1952 91 3.5k
Stefan Faderl 1700 1908 1017 113 3.5k
Emilio Montserrat 2318 1334 1989 84 4.1k
John Catalano 1117 873 893 53 2.2k
J M Bennett 1757 1988 1166 39 4.0k
Achille Ambrosetti 1315 786 1506 66 2.8k
D. K. Hossfeld 1373 1178 2266 53 4.4k
Marı́a Rozman 2091 1365 1569 126 3.5k
Preetesh Jain 2050 1376 1407 179 3.4k
E Montserrat 1374 758 1738 96 3.0k

All Works

Loading papers...

Rankless by CCL
2026